SIDRAH KHAN: Open Payments
NPI 1073280434 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 43 payments from 16 companies in 2025. Trend: 2023 $1,235 · 2024 $2,264 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $157 |
| ABBVIE INC. | 9 | $145 |
| ViiV Healthcare Company | 5 | $135 |
| Novo Nordisk Inc | 5 | $117 |
| Amgen Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Gilead Sciences, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $29 |
Products named: APRETUDE, ELIQUIS, OTEZLA, MOUNJARO, Ozempic, NURTEC ODT, Wegovy, PREVNAR 20.
Industry payments across DC — which companies pay providers there.
